Rezultati - Charlene Lin
- Showing 1 - 3 results of 3
-
1
Immune effector monocyte–neutrophil cooperation induced by the primary tumor prevents metastatic progression of breast cancer od Catharina Hagerling, Hugo González, Kiarash Salari, Chih‐Yang Wang, Charlene Lin, Isabella Robles, Merel van Gogh, Annika Dejmek, Karin Jirström, Zena Werb
Izdano 2019Artigo -
2
LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic target od Catharina Hagerling, Mark Owyong, Vaishnavi Sitarama, Chih‐Yang Wang, Charlene Lin, Renske J.E. van den Bijgaart, Charlotte D. Koopman, Audrey Brenot, Ankitha Nanjaraj, Fredrik Wärnberg, Karin Jirström, Ophir D. Klein, Zena Werb, Vicki Plaks
Izdano 2020Artigo -
3
MMP9 modulates the metastatic cascade and immune landscape for breast cancer anti-metastatic therapy od Mark Owyong, Jonathan Chou, Renske J.E. van den Bijgaart, Niwen Kong, Gizem Efe, Carrie Maynard, Dalit Talmi-Frank, Inna Solomonov, Charlotte D. Koopman, Elin Hadler‐Olsen, Mark B. Headley, Charlene Lin, Chih‐Yang Wang, Irit Sagi, Zena Werb, Vicki Plaks
Izdano 2019Artigo
Iskalna orodja:
Sorodne teme
Biology
Breast cancer
Cancer
Cancer research
Internal medicine
Medicine
Biochemistry
Immunology
Metastatic breast cancer
Biomarker
Cancer stem cell
Carcinogenesis
Downregulation and upregulation
Ductal carcinoma
Effector
Gene
Immune system
Innate immune system
LGR5
MMP9
Metastasis
Monocyte
Oncology
Pathology